Author: Jordan Bouclin

26 Oct TissueGen’s Dr. Kevin Nelson to Participate on “Drug Delivery Devices” Track at University of Texas System FreshAIR Initiative

WHO: Dr. Kevin Nelson, founder and CSO of TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery. WHAT: Dr. Nelson will present a segment titled “Advanced Drug Delivery from Biodegradable Polymers with ELUTE® Fiber" as part of the breakout "Drug...

Read More

15 Oct TissueGen to Exhibit ELUTE® Fiber at SfN’s Neuroscience 2015

WHO: TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. WHAT: TissueGen, Inc. will showcase ELUTE® fiber in Booth 1827 at the Society for Neuroscience’s annual meeting, Neuroscience 2015. TissueGen’s ELUTE fiber - available in pharmaceutical...

Read More

01 Sep TissueGen to Showcase ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at TERMIS World Congress

WHO: TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. WHAT: The theme for this year’s TERMIS World Congress is "Past, Present Future: The Evolution of Regenerative Medicine," reflecting the impact of tissue engineering throughout...

Read More

23 Jun TissueGen Appoints Dr. Jennifer Seifert as Senior Scientist to Lead Spinal Cord Injury Repair Program

Dallas, TX, June 23, 2015 – TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced that Jennifer Seifert, Ph.D., has joined the company in the newly established role of Senior Scientist. Seifert will lead TissueGen’s application of...

Read More

01 Jun TissueGen Showcases Groundbreaking ELUTE® Fiber for Implantable Drug Delivery at MD&M East

ELUTE® Fiber Ideal for Advanced Drug Delivery, Nerve Regeneration, and Tissue Engineering WHO: TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. WHAT: At MD&M East, TissueGen will be exhibiting its ELUTE fiber in Booth 515....

Read More

04 Feb TissueGen to Showcase ELUTE Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering Applications at MD&M West

WHO: TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery nerve regeneration and tissue engineering. WHAT: At MD&M West, TissueGen will be exhibiting its ELUTE fiber in booth #2996. TissueGen uses a patented, cutting-edge room temperature extrusion process to enable...

Read More

03 Feb TissueGen CSO to Deliver Keynote Session at Purdue University’s Biomedical Engineering Graduate Student Association Research Symposium

Dr. Kevin Nelson to Speak on “Falling up: Life Lessons Learned Moving from the Black Board to the Board Room” on February 5th Dallas, TX, February 3, 2015 – Dr. Kevin Nelson, founder and CSO of TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber...

Read More